Periovulatory serum human chorionic gonadotropin (hCG) concentrations following subcutaneous and intramuscular nonrecombinant hCG use during ovulation induction: A prospective, randomized trial

Fertility and Sterility

Volumn 76, Issue 2, 2001, Pages 397-399

  Sills, E Scott ^a   Drews, Carey D ^b   Perloe, Mark ^a   Kaplan, Carolyn R ^a   Tucker, Michael J ^a  

^a Georgia Reproductive Specialists ^*  (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

hCG; Injection; Intramuscular; Ovulation induction; Subcutaneous

Indexed keywords

CHORIONIC GONADOTROPIN;

ADULT; AGE; ARTICLE; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG TOLERABILITY; FEMALE; FEMALE INFERTILITY; HORMONAL THERAPY; HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; LEAN BODY WEIGHT; NORMAL HUMAN; OVARY; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PREGNANCY RATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STIMULATION;

ADULT; CHORIONIC GONADOTROPIN; FEMALE; HUMANS; INFERTILITY, FEMALE; INJECTIONS, INTRAMUSCULAR; INJECTIONS, SUBCUTANEOUS; OVULATION; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS;

EID: 0034900165     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(01)01903-3     Document Type: Article

References (10)

1. Ovulation after intravenous and intramuscular human chorionic gonadotropin
2. Human chorionic gonadotropin: Pharmacokinetics of subcutaneous administration
3. Pharmacodynamics and pharmacokinetics after subcutaneous and intramuscular injection of human chorionic gonadotropin
4. A randomized three-way cross-over study in healthy pituitary-suppressed women to compare the bioavailability of human chorionic gonadotropin (Pregnyl) after intramuscular and subcutaneous administration
5. Characteristics of consecutive in vitro fertilization cycles among patients treated with follicle-stimulating hormone (FSH) and human menopausal gonadotropin versus FSH alone
6. Treatment of hypo-ovarianism by the sequential and cyclic administration of equine and chorionic gonadotropins - So-called one-two cyclic gonadotropin therapy
7. Reducing discomfort from IM injections
8. Recombinant human lutenizing hormone: An effective new gonadotropin preparation
9. A prospective, randomized comparison of ovulation induction using highly purified follicle-stimulating hormone alone and with recombinant human luteinizing hormone in in-vitro fertilization
10. Serum human chorionic gonadotropin levels are correlated with body mass index rather than route of administration in women undergoing in vitro fertilization-embryo transfer using human menopausal gonadotropin and intracytoplasmic sperm injection